mhurhangee/ep-ind-claims huggingface dataset:
A method for operating a computing device in which a processing subsystem executes a first application in a first sandbox that prevents direct access by the first application to data and resources in the computing device that are outside the first sandbox and prevents direct access by a second application to data and resources within the first sandbox, comprising: in the processing subsystem, performing operations for a broker application, the broker application being permitted access to the data and resources in the first sandbox, the operations comprising: communicating with the second application to acquire configuration information for a mediated data exchange from the second application; determining whether the second application has denied the mediated data exchange between the first application and the second application in the computing device based on a control set by the second application; in response to determining that the second application has not denied the mediated data exchange, performing the mediated data exchange between the first application and the second application in the computing device based on the control, the mediated data exchange comprising, when importing data from the second application to the first application, receiving the data from the second application in the broker application and forwarding the received data from the broker application to the first application within the first sandbox; and in response to determining that the second application has denied the mediated data exchange, terminating the mediated data exchange. communicating with the second application to acquire configuration information for a mediated data exchange from the second application; determining whether the second application has denied the mediated data exchange between the first application and the second application in the computing device based on a control set by the second application; in response to determining that the second application has not denied the mediated data exchange, performing the mediated data exchange between the first application and the second application in the computing device based on the control, the mediated data exchange comprising, when importing data from the second application to the first application, receiving the data from the second application in the broker application and forwarding the received data from the broker application to the first application within the first sandbox; and in response to determining that the second application has denied the mediated data exchange, terminating the mediated data exchange.
An outerwear comprising a front, a back, sleeve parts, and side parts, wherein the front, the back, the sleeve parts, and the side parts are provided with cold protection regions (R1, R2, R4, R5) filled with a cold-proof material, the front only includes a down region in an upper part of the front, the down region being filled only with down, and the back only includes a down region in an upper part of the back, the down region being filled only with down, characterized in that the sleeve part only includes a cotton region over the sleeve part, the cotton region being filled only with a cotton material, and the side part only includes a cotton region in a lower part of the side part, the cotton region being filled only with a cotton material. the front, the back, the sleeve parts, and the side parts are provided with cold protection regions (R1, R2, R4, R5) filled with a cold-proof material, the front only includes a down region in an upper part of the front, the down region being filled only with down, and the back only includes a down region in an upper part of the back, the down region being filled only with down, characterized in that the sleeve part only includes a cotton region over the sleeve part, the cotton region being filled only with a cotton material, and the side part only includes a cotton region in a lower part of the side part, the cotton region being filled only with a cotton material.
A liquid detergent comprising from about 5% to about 20% by weight thereof of a surfactant system wherein the surfactant system comprises an alkoxylated anionic surfactant having and alkoxylation degree of from 0.20 to 1.75 and wherein the detergent at 20°C has a pouring viscosity of from about 2500 mPa s to about 6000 mPa s and a ratio of medium to high shear viscosity of from about 2 to about 1 as measured as specified in the description.
A liquid ejection head (2, 102, 202) comprising: a first channel member comprising a first surface, a plurality of ejection ports in the first surface, a plurality of pressurizing chambers which are individually communicated with the plurality of ejection ports, and a second surface on the opposite side to the first surface; a pressurizing member on the second surface; and a second channel member (6, 106, 206) comprising a first channel inside it, a third surface (6-3, 106-3, 206-3), a fourth surface (6-4, 106-4, 206-4) on the opposite side to the third surface (6-3, 106-3, 206-3), a raised part (6e, 106e, 206e) which protrudes from the fourth surface (6-4, 106-4, 206-4), and a first through hole (6a, 106a, 206a) in the raised part (6e, 106e, 206e); wherein the second channel member (6, 106, 206) is provided with its third surface (6-3, 106-3, 206-3) on a region in the second surface of the first channel member, the pressurizing member being not arranged on the region, and when viewed on a plane, an outer circumference (7a, 107a) of the raised part (6e, 106e, 206e) is located on inner side from an outer circumference of the fourth surface (6-4, 106-4, 206-4), characterized in that a signal transmission member which transmits a signal to the pressurizing member is led out upward in a state where it contacts the raised part (6e, 106e, 206e) configuring the first through hole (6a, 106a, 206a). a first channel member comprising a first surface, a plurality of ejection ports in the first surface, a plurality of pressurizing chambers which are individually communicated with the plurality of ejection ports, and a second surface on the opposite side to the first surface; a pressurizing member on the second surface; and a second channel member (6, 106, 206) comprising a first channel inside it, a third surface (6-3, 106-3, 206-3), a fourth surface (6-4, 106-4, 206-4) on the opposite side to the third surface (6-3, 106-3, 206-3), a raised part (6e, 106e, 206e) which protrudes from the fourth surface (6-4, 106-4, 206-4), and a first through hole (6a, 106a, 206a) in the raised part (6e, 106e, 206e); wherein the second channel member (6, 106, 206) is provided with its third surface (6-3, 106-3, 206-3) on a region in the second surface of the first channel member, the pressurizing member being not arranged on the region, and when viewed on a plane, an outer circumference (7a, 107a) of the raised part (6e, 106e, 206e) is located on inner side from an outer circumference of the fourth surface (6-4, 106-4, 206-4), characterized in that a signal transmission member which transmits a signal to the pressurizing member is led out upward in a state where it contacts the raised part (6e, 106e, 206e) configuring the first through hole (6a, 106a, 206a).
A virus-like particle comprising one or more Cas9 protein(s), said one or more Cas9 protein(s) being contained inside the virus-like particle as a fusion protein between (i) a viral structural protein which is a retroviral gag protein and (ii) the one or more Cas9 protein(s), said VLP further comprising one or more CRISPR-Cas system guide RNA(s) inside the VLP, and further comprising one or more viral envelope protein(s).
A random copolymer comprising a first monomer, a second monomer, and a branched initiator fragment, wherein the first monomer comprises a phosphorylcholine, and the second monomer comprises a first functional agent, wherein the first and the second monomer are distributed randomly throughout the copolymer; wherein the random copolymer has multiple polymer arms polymerized from the branched initiator fragment, and the first functional agent is selected from the group consisting of a therapeutic protein, an antibody or antibody fragment, a drug, a vaccine, a vitamin, a cofactor, a polysaccharide, a carbohydrate, a steroid, a lipid, a fat, a peptide, a protein, a polypeptide, a nucleotide, an oligonucleotide, a nucleic acid, a detection agent, an imaging agent, a labeling agent, and a diagnostic agent.
Switch for interruption of a direct current circuit, wherein two DC electric voltage sources (S1, S2) are integrated within said circuit, which are in serial connected with each other and are both via a main electric conductor electrically connected with at least one electric load, wherein said main electric conductor is in the area between said electric voltage sources (S1, S2) and said load bridged by a supplemental electric conductor, which is in parallel electrically connected with said sources (S1, S2) and also with said load, and is prior to activation of the switch, namely during regular operation of the electric circuit, interrupted by means of a gap and is consequently electrically impermeable, while in the intermediate area between said connecting points (100', 100") said main conductor is furnished with a removable section, which is in pre-determined conditions removable apart from the main conductor and irreversibly displaceable into the gap in said supplemental electric conductor, which herewith becomes electrically conductive, while simultaneously the main electric conductor upon removing said section there-from becomes electrically impermeable, characterized in that an electrically conductive branch with integrated electric fuse with a melting member is in parallel connected on the one hand to said load and on the other hand also to said main conductor in two apart from each other located connecting points (100', 100") in the area between both electric voltage sources (S1, S2). while in the intermediate area between said connecting points (100', 100") said main conductor is furnished with a removable section, which is in pre-determined conditions removable apart from the main conductor and irreversibly displaceable into the gap in said supplemental electric conductor, which herewith becomes electrically conductive, while simultaneously the main electric conductor upon removing said section there-from becomes electrically impermeable, characterized in that an electrically conductive branch with integrated electric fuse with a melting member is in parallel connected on the one hand to said load and on the other hand also to said main conductor in two apart from each other located connecting points (100', 100") in the area between both electric voltage sources (S1, S2).
A method for detecting the presence of a microorganism in a sample, wherein polymerase activity is detected as an indicator of the presence of said microorganism in said sample, which method comprises: (a) contacting the sample with a nucleic acid molecule which acts as a substrate for polymerase activity in the sample; (b) incubating the thus contacted sample under conditions suitable for polymerase activity; and (c) specifically determining the presence (and/or the amount) of a nucleic acid molecule resulting from the action of the microorganism polymerase on the substrate by nucleic acid amplification of the nucleic acid molecule, thereby to indicate the presence of the microorganism. (a) contacting the sample with a nucleic acid molecule which acts as a substrate for polymerase activity in the sample; (b) incubating the thus contacted sample under conditions suitable for polymerase activity; and (c) specifically determining the presence (and/or the amount) of a nucleic acid molecule resulting from the action of the microorganism polymerase on the substrate by nucleic acid amplification of the nucleic acid molecule, thereby to indicate the presence of the microorganism.
A cardiopulmonary resuscitation, CPR, device (100, 200, 400) for delivering intrathoracic pressure pulses to a subject, the device comprising an air pressure generator (110, 310, 410) for delivering air to the airways of the subject, wherein the air pressure generator (110, 310, 410) is configured to: - operate a first mode, wherein in the first mode the air pressure generator (110, 310, 410) generates a first output (412, 770a, 770b) comprising a first plurality of positive pressure pulses for temporally increasing the subject's intrathoracic pressure to induce compressions of the heart of the subject by increasing the volume of the subject's lungs; - operate a second mode, wherein in the second mode the air pressure generator (110, 310, 410) generates a second output (414, 880) comprising a second plurality of positive pressure pulses for providing an assured airflow to the lungs of the subject; and - deliver a resulting output (425, 986, 1086) to the airways of the subject, the resulting output being the superposition of the first output (412, 770a, 770b) and of the second output (414, 880); wherein said first plurality of positive pressure pulses have an amplitude greater than 30 mbar and a frequency in a range of 40-240 beats per minute; and wherein said second plurality of positive pressure pulses have an amplitude smaller than 30 mbar and a frequency in a range of 3 to 20 cycles per minute. - operate a first mode, wherein in the first mode the air pressure generator (110, 310, 410) generates a first output (412, 770a, 770b) comprising a first plurality of positive pressure pulses for temporally increasing the subject's intrathoracic pressure to induce compressions of the heart of the subject by increasing the volume of the subject's lungs; - operate a second mode, wherein in the second mode the air pressure generator (110, 310, 410) generates a second output (414, 880) comprising a second plurality of positive pressure pulses for providing an assured airflow to the lungs of the subject; and - deliver a resulting output (425, 986, 1086) to the airways of the subject, the resulting output being the superposition of the first output (412, 770a, 770b) and of the second output (414, 880);
A method for information processing in ultra-reliable low latency communication, URLLC, transmissions for new radio, NR, the method being executed by a terminal device and comprising: determining first information corresponding to first downlink control information, DCI, wherein the first information is used for multiplexing and transmitting acknowledgement/negative acknowledgement, ACK/NACK, information corresponding to physical channels in a target group through an uplink channel, wherein the target group is a group in which corresponding ACK/NACK information is triggered for transmission, and wherein a physical channel corresponding to the first DCI is associated with priority information, and wherein the physical channel corresponding to the first DCI comprises a physical downlink shared channel, PDSCH, scheduled by the first DCI; wherein the first DCI is DCI format 1_2; wherein the first information comprises triggering feedback group information; wherein the triggering feedback group information is determined according to a first correspondence and a fourth information field in the first DCI, wherein the first correspondence is a correspondence between indication results of an information field and group information, and the first correspondence is agreed according to a protocol. determining first information corresponding to first downlink control information, DCI, wherein the first information is used for multiplexing and transmitting acknowledgement/negative acknowledgement, ACK/NACK, information corresponding to physical channels in a target group through an uplink channel, wherein the target group is a group in which corresponding ACK/NACK information is triggered for transmission, and wherein a physical channel corresponding to the first DCI is associated with priority information, and wherein the physical channel corresponding to the first DCI comprises a physical downlink shared channel, PDSCH, scheduled by the first DCI; wherein the first DCI is DCI format 1_2; wherein the first information comprises triggering feedback group information; wherein the triggering feedback group information is determined according to a first correspondence and a fourth information field in the first DCI, wherein the first correspondence is a correspondence between indication results of an information field and group information, and the first correspondence is agreed according to a protocol.
An interleukin-22 (IL-22) Fc fusion protein for use in preventing acute GVHD, reducing the risk of developing chronic GVHD, or reducing the risk of corticosteroid-refractory acute GVHD in a subject comprising administering to a subject in need thereof an IL-22 Fc fusion protein in a dosing regimen comprising a dosing cycle, wherein the dosing cycle comprises up to and no more than six total doses of the IL-22 Fc fusion protein, wherein the dosing cycle comprises a first dose (C1D1) and one or more further doses, wherein each dose is about 60 μg/kg, and wherein the doses are administered to the subject q1w, (every week) q2w, (every two weeks) q3w, (every three weeks) or q4w, (every four weeks) and wherein the IL-22 Fc fusion protein comprises the amino acid sequence of SEQ ID NO:8.
A cable transportation system comprising: - a first terminal station; - a second terminal station; - a plurality of transporting units moved between the terminal stations (2, 3); - at least one supporting cable for supporting the transporting units between the terminal stations (2, 3); wherein the supporting cable comprises a first end housed inside the first terminal station and a second end housed inside the second terminal station; - a first anchor device for anchoring the first end of the supporting cable inside the first terminal station; - a second anchor device for anchoring the second end of the supporting cable inside the second terminal station; wherein the anchor devices (8, 9) are configured to selectively block the ends (6, 7) of the supporting cable inside the respective terminal stations (2, 3) and to allow a stepped sliding of the supporting cable between the terminal stations (2, 3); wherein the second anchor device comprises a molten head for receiving the second end of the supporting cable, a guiding device for guiding the molten head, a blocking pin, wherein the molten head comprises a hole for receiving the blocking pin and the guiding device comprises a plurality of through holes so that the molten head can be anchored by the blocking pin to the guiding device in a plurality of positions. - a first terminal station; - a second terminal station; - a plurality of transporting units moved between the terminal stations (2, 3); - at least one supporting cable for supporting the transporting units between the terminal stations (2, 3); wherein the supporting cable comprises a first end housed inside the first terminal station and a second end housed inside the second terminal station; - a first anchor device for anchoring the first end of the supporting cable inside the first terminal station; - a second anchor device for anchoring the second end of the supporting cable inside the second terminal station; wherein the anchor devices (8, 9) are configured to selectively block the ends (6, 7) of the supporting cable inside the respective terminal stations (2, 3) and to allow a stepped sliding of the supporting cable between the terminal stations (2, 3); wherein the second anchor device comprises a molten head for receiving the second end of the supporting cable, a guiding device for guiding the molten head, a blocking pin, wherein the molten head comprises a hole for receiving the blocking pin and the guiding device comprises a plurality of through holes so that the molten head can be anchored by the blocking pin to the guiding device in a plurality of positions.
A method of controlling a sleep mode in a portable terminal having a main controller and a sub-controller operating at low power, the method comprising: detecting, by the sub-controller, a motion signal generated by a camera when the main controller is in a sleep mode; extracting a motion pattern from the detected motion signal; comparing the extracted motion pattern to a preset motion wake-up pattern; and cancelling the sleep mode by waking-up the main controller depending on the outcome of the comparison between the extracted motion pattern and the motion wake-up pattern. detecting, by the sub-controller, a motion signal generated by a camera when the main controller is in a sleep mode; extracting a motion pattern from the detected motion signal; comparing the extracted motion pattern to a preset motion wake-up pattern; and cancelling the sleep mode by waking-up the main controller depending on the outcome of the comparison between the extracted motion pattern and the motion wake-up pattern.
An ex-vivo method of producing a substantially pure, educated, expanded, antigen- specific population of immune effector cells, wherein the immune effector cells are T-lymphocytes and wherein said population comprises CD4+ immune effector cells and cytotoxic CD8+ immune effector cells, the method comprising: (a) providing a plurality of hybrid cells, each of which hybrid cells is generated by fusion between at least one dendritic cell and at least one tumor or cancer cell that expresses a cell-surface antigen, wherein the dendritic cell and the tumor or cancer cell are from the same species, wherein the dendritic cell can process and present antigens, and wherein at least half of the hybrid cells express, in an amount effective to stimulate the immune system, (i) MHC class II molecule, (ii) B7, and (iii) the cell-surface antigen; (b) contacting a population of immune effector cells with the plurality of hybrid cells, thereby producing a population of educated, antigen-specific immune effector cells; and (c) contacting said population of educated, antigen-specific immune effector cells with anti-CD3/CD28 antibody, wherein said contacting results in an increase in T cell expansion, T cell activity, or tumor-reactive T cells as compared to exposure to said hybrid cells alone, or to said anti-CD3/CD28 antibody alone, thereby producing the substantially pure, expanded, educated, antigen-specific population of immune effector cells. (a) providing a plurality of hybrid cells, each of which hybrid cells is generated by fusion between at least one dendritic cell and at least one tumor or cancer cell that expresses a cell-surface antigen, wherein the dendritic cell and the tumor or cancer cell are from the same species, wherein the dendritic cell can process and present antigens, and wherein at least half of the hybrid cells express, in an amount effective to stimulate the immune system, (i) MHC class II molecule, (ii) B7, and (iii) the cell-surface antigen; (i) MHC class II molecule, (ii) B7, and (iii) the cell-surface antigen; (b) contacting a population of immune effector cells with the plurality of hybrid cells, thereby producing a population of educated, antigen-specific immune effector cells; and (c) contacting said population of educated, antigen-specific immune effector cells with anti-CD3/CD28 antibody, wherein said contacting results in an increase in T cell expansion, T cell activity, or tumor-reactive T cells as compared to exposure to said hybrid cells alone, or to said anti-CD3/CD28 antibody alone, thereby producing the substantially pure, expanded, educated, antigen-specific population of immune effector cells.